Archive for the ‘informa healthcare’ Category
The article, “Testosterone therapy improves psychological distress and health-related quality of life in Chinese men with symptomatic late-onset hypogonadism patients,” came from a group at Peking University People’s Hospital, in Beijing.
But as the retraction notice explains: Read the rest of this entry »
Pharmaceutical Biology has retracted a 2012 paper by a group of liver researchers from China after the discovery of an error that evidently invalidated the results in the paper.
The article, “Antifibrotic effects of protocatechuic aldehyde on experimental liver fibrosis,” purported to show that
protocatechuic aldehyde, the major degradation of phenolic acids … has potentially conferring antifibrogenic effects.
The research involved looking at concentrations of blood fats in athletes and less vigorous folk, “and to examine the risks of cardiovascular diseases.”It found that:
… medium and high level of exercises did not cause significant differences in lipid and lipoprotein levels, but the sex differences were very pronounced” with “lipid and lipoprotein profile of female subjects was found to be better than that of males”.
The Journal of Maternal-Fetal & Neonatal Medicine has retracted a 2008 article on smoking cessation by a group from Sweden which they had published not many months before in a different journal.
The retracted paper was titled “Quitting smoking is perceived to have an effect on somatic health among pregnant and non-pregnant women.” The authors, from the Royal Institute of Technology in Stockholm, had published a similar paper — “Perception of Smoking-Related Health Consequences among Pregnant and Non-Pregnant Women” — in the American Journal of Addictions in 2007.
A top cardiology researcher, Robert Hegele, of the Robarts Research Institute at the University of Western Ontario, has retracted a 15-year-old review after editors were made aware that it was “very similar” to another of his reviews.
Expert Opinion on Investigational Drugs has a new one in the annals of penitence. At issue is a 2010 paper titled “Horizon scanning for novel therapeutics for the treatment of prostate cancer,” by Dieletta Bianchini. Turns out the authors had published the same (or nearly so) paper two months earlier in a different journal. Here’s the notice: Read the rest of this entry »
Hyung-In Moon, the South Korean plant compound researcher who made up email addresses so he could do his own peer review, is now up to 35 retractions.
The four new retractions are of the papers in the Journal of Enzyme Inhibition and Medicinal Chemistry that initially led to suspicions when all the reviews came back within 24 hours. Here’s the notice, which includes the same language as Moon’s 24 other retractions of studies published in Informa Healthcare journals: Read the rest of this entry »
Journal editor resigned in wake of retractions for fake email addresses that enabled self-peer review
The case of Hyung-In Moon — the researcher who faked email addresses for potential peer reviewers so he could do his own peer review — has already led to one resignation.